Chronic Heart Failure
Springer Berlin (Verlag)
978-3-540-63579-6 (ISBN)
Prof. Dr. med. Erland Erdmann ist Direktor der Klinik III für Innere Medizin (Kardiologie, Angiologie, Pneumologie und Internistische Intensivmedizin) am Klinikum der Universität zu KölnTagungspräsident des Kardiologenkongresses 04/2003 -2007; mit dem Bundesverdienstkreuz 1. Klasse ausgezeichnet
1 Definition.- 2 Epidemiology.- 3 Normal and Pathological Anatomy.- 4 Pathophysiology.- 4.1 Molecular Mechanisms of Contraction.- 4.2 Regulation of the Contractile Force.- 4.3 Compensatory Mechanisms.- 4.4 Determinants and Assessment of the Cardiac Function.- 4.5 Blood Supply of the Organs and Cardiac Output Capacity.- 4.6 Musculoskeletal Metabolism in Heart Failure.- 4.7 Vascular periphery in Heart Failure.- 4.8 Pathogenesis of Cardiac Oedema.- 5 Clinical Course and Symptomatology.- 5.1 Forward and Backward Failure.- 5.2 Systolic and Diastolic Heart Failure.- 5.3 Low-Output and High-Output Heart Failure.- 5.4 Acute and Chronic Heart Failure.- 5.5 Classification Criteria for Heart Failure (Revised NYHA Classification).- 6 Diagnosis and Differential Diagnosis of Heart Failure.- 6.1 Principles of Diagnosis.- 6.2 Diagnostic Procedures, Overview.- 6.3 History.- 6.4 Physical Examination.- 6.5 ECG.- 6.6 Radiological Examination of the Thorax.- 6.7 Echocardiography and Doppler Echocardiography.- 6.8 Heart Catheterization.- 6.9 Myocardial Biopsy.- 6.10 Computed Tomography.- 6.11 Nuclear Spin Tomography.- 6.12 Nuclear Medicine Procedures.- 6.13 New Haemodynamic Monitoring Methods.- 6.14 Conclusions.- 7 Principles of Therapy.- 7.1 General and Specific Therapy.- 7.2 Aims of Therapy.- 8 Therapy with Cardiac Glycosides.- 8.1 Mechanism of Action.- 8.2 Pharmacokinetics.- 8.3 Pharmacodynamics.- 8.4 Age-Dependent Regulation of the Cardiac Glycoside Receptors.- 8.5 Effect on the Failing Myocardium.- 8.6 Interaction of Drugs with Digitalis.- 8.7 Measurement of the Digitalis Concentration in the Blood.- 8.8 Cardiac Glycosides in Atrial Fibrillation and Flutter.- 8.9 Cardiac Glycosides in Sinus Tachycardia and Paroxysmal Atrial Fibrillation.- 8.10 Cardiac Glycosides in Acute Heart Failure.-8.11 Cardiac Glycosides in Myocardial Infarction.- 8.12 Cardiac Glycosides in Chronic Heart Failure.- 8.13 Lacking Indication for Digitalis.- 8.14 Choosing the Cardiac Glycoside.- 8.15 Dosage of Digoxin and its Derivates.- 8.16 Side Effects and Intoxication.- 8.17 Therapy of Cardiac Glycoside Intoxication.- 8.18 Contraindications for Cardiac Glycosides.- 9 Therapy with Diuretics.- 9.1 Classification According to the Site of Action.- 9.2 Classification According to Potency.- 9.3 Side Effects of Diuretic Therapy.- 9.4 Other Fluid Liquid Extraction Methods.- 9.10 General Hypokalaemia.- 10 Therapy with ACE Inhibitors.- 10.1 Pharmacodynamics.- 10.2 Pharmacokinetics.- 10.3 Established Indications.- 10.4 Effects on Left Ventricular Dilatation.- 10.5 Dosage.- 10.6 Choosing the right ACE Inhibitor.- 10.7 Side Effects:.- 10.8 Interaction with Other Drugs.- 10.9 Contraindications.- 10.10 Treatment with Other Vasodilators.- 11 Therapy with Other Drugs.- 11.1 Calcium Antagonists.- 11.2 Inodilators (cAMP Phosphodiesterase Inhibitors).- 11.3 Catecholamines.- 11.4 ?-Receptor Blockers.- 11.5 Experimental Therapies.- 11.6 Antiarrhythmic Therapy in Cases of Heart Failure.- 11.7 Pacemaker Therapy.- 11.8 Surgical Therapy of Heart Failure (Cardiomyoplasty).- 11.9 Anticoagulation.- 11.10 Acutely Deteriorated and Therapy-Resistant Heart Failure.- 12 Mechanical Circulatory Support.- 12.1 Indications and Contraindications.- 12.2 Methods.- 12.3 Prognosis.- 13 The Ageing Heart.- 13.1 Ageing and Physical Strain.- 13.2 Morphological Changes.- 13.3 Functional Changes.- 13.4 Cardiac Regulation in the Elderly under Strain.- 13.5 Cardiac Diseases in the Elderly.- 13.6 Summary and Conclusions.- 14 Aspects of Altered Gene Expression in Heart Failure and Myocardial Hypertrophy.- 14.1 Examination of theProtein Biosynthesis and Gene Expression.- 14.2 Structure and Function of the Contractile Apparatus.- 14.3 Contractile Apparatus in Cardiac Hypertrophy and Heart Failure.- 14.4 Intracellular Calcium Homeostasis.- 14.5 Signal Transduction in the Cell Membrane.- 14.6 Clinical Consequences.- References.
Erscheint lt. Verlag | 24.11.1997 |
---|---|
Co-Autor | W.von Scheidt, M. Wankerl |
Zusatzinfo | XII, 276 p. 122 illus., 81 illus. in color. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 1 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
Schlagworte | anatomy • Atrial Fibrillation • cardiac function • Diagnostics • Differential Diagnosis • Dilatation • Echocardiography • electrocardiogram (ECG) • heart • Herzinsuffizienz |
ISBN-10 | 3-540-63579-3 / 3540635793 |
ISBN-13 | 978-3-540-63579-6 / 9783540635796 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich